Latest Articles

Open Access
KRAS Mutations in Cholangiocarcinoma: Prevalence, Prognostic Value, and KRAS G12/G13 Detection in Cell-Free DNA
PITCHASAK THONGYOO, JARIN CHINDAPRASIRT, CHAIWAT APHIVATANASIRI, PIYAPHAROM INTARAWICHIAN, WARITTA KUNPROM, SARINYA KONGPETCH, ANCHALEE TECHASEN, WATCHARIN LOILOME, NISANA NAMWAT, ATTAPOL TITAPUN and APINYA JUSAKUL

Cancer Genomics & Proteomics January 2025, 22 (1) 112-126; DOI: https://doi.org/10.21873/cgp.20492
Open Access
FAM32A Suppression Decreases 5-Fluorouracil-induced Apoptosis and Is Associated With Poor Prognosis in Gastric Cancer
YUYA AGATSUMA, DAI SHIMIZU, SHINICHI UMEDA, HARUYOSHI TANAKA, NORIFUMI HATTORI, MASAMICHI HAYASHI, MITSURO KANDA, CHIE TANAKA, GORO NAKAYAMA, MICHITAKA FUJIWARA and YASUHIRO KODERA

Cancer Genomics & Proteomics January 2025, 22 (1) 55-69; DOI: https://doi.org/10.21873/cgp.20487
Open Access
Regulation and Function of CCL2 and N-Myc in Retinoic Acid-treated Neuroblastoma Cells
NANKE MURRA, NINA SOPHIE POMMERT, BERIT SCHMIDT, REEMA SAMI ISSA, MEIKE KAEHLER, HENRIKE BRUCKMUELLER, VERA TIM, INGOLF CASCORBI and VICKI WAETZIG

Cancer Genomics & Proteomics January 2025, 22 (1) 90-102; DOI: https://doi.org/10.21873/cgp.20490
Open Access
Impact of Hypoxia and the Levels of Transcription Factor HIF-1α and JMJD1A on Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma Cell Lines
ARMIN VON FOURNIER, CHRISTIAN WILHELM, CLARA TIRTEY, MANUEL STÖTH, TOTTA EHRET KASEMO, STEPHAN HACKENBERG and AGMAL SCHERZAD

Cancer Genomics & Proteomics November 2024, 21 (6) 591-607; DOI: https://doi.org/10.21873/cgp.20476
Open Access
Serum Exosomes Expressing CD9, CD63 and HER2 From Breast-Cancer Patients Decreased After Surgery of the Primary Tumor: A Potential Biomarker of Tumor Burden
SACHIKO INUBUSHI, TOMONARI KUNIHISA, MARINA KUNIYASU, SHOTARO INOUE, MAYUKO YAMAMOTO, YUJI YAMASHITA, MAYUKO MIKI, SACHIKO MIZUMOTO, MOTOI BABA, ROBERT M. HOFFMAN and HIROKAZU TANINO

Cancer Genomics & Proteomics November 2024, 21 (6) 580-584; DOI: https://doi.org/10.21873/cgp.20474
Open Access
Cordycepin Activates Autophagy to Suppress FGF9-induced TM3 Mouse Leydig Progenitor Cell Proliferation
SU-ZHEN WU, YU-YAN LAN, CHIN-YING CHEN, LI-CHING CHEN and BU-MIIN HUANG

Cancer Genomics & Proteomics November 2024, 21 (6) 630-644; DOI: https://doi.org/10.21873/cgp.20479
Open Access
GD2 in Breast Cancer: A Potential Biomarker and Therapeutic Target
KEFAH MOKBEL

Cancer Genomics & Proteomics November 2024, 21 (6) 549-556; DOI: https://doi.org/10.21873/cgp.20471
Open Access
Suppressing Expression of SERPINE1/PAI1 Through Activation of GPER1 Reduces Progression of Vulvar Carcinoma
TAMMY DOELKER, JULIA GALLWAS and CARSTEN GRÜNDKER

Cancer Genomics & Proteomics November 2024, 21 (6) 566-579; DOI: https://doi.org/10.21873/cgp.20473
Open Access
SF3B4 Regulates Cellular Senescence and Suppresses Therapy-induced Senescence of Cancer Cells
SEUNGYEON YANG, MINBEOM KO, SOOJUNG CLAIRE HUR, EUN KYUNG LEE and SEUNG MIN JEONG

Cancer Genomics & Proteomics November 2024, 21 (6) 622-629; DOI: https://doi.org/10.21873/cgp.20478
Open Access
Extensive DNA Damage and Loss of Cell Viability Occur Synergistically With the Combination of Recombinant Methioninase and Paclitaxel on Pancreatic Cancer Cells which Report DNA-Damage Response in Real Time
SEI MORINAGA, QINGHONG HAN, KOHEI MIZUTA, BYUNG MO KANG, MOTOKAZU SATO, MICHAEL BOUVET, NORIO YAMAMOTO, KATSUHIRO HAYASHI, HIROAKI KIMURA, SHINJI MIWA, KENTARO IGARASHI, TAKASHI HIGUCHI, HIROYUKI TSUCHIYA, SATORU DEMURA and ROBERT M. HOFFMAN

Cancer Genomics & Proteomics November 2024, 21 (6) 585-590; DOI: https://doi.org/10.21873/cgp.20475

Main menu

User menu

Search

Latest Articles

Pages